P

PVLA

Palvella Therapeutics Inc

155.07

Aug 12 • 3:59 PM ET +0.77 (0.50%)

155.07

Aftermarket • 4:15 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Mid NASD

Peers: KYMR MANE ORKA RYTM KRYS BMRN CRNX INCY AXSM NBIX

| Held by: XBI VTI IWM VXF IWO VTWO VHT VFMO LFSC SBIO

Scroll to Statements

Index	RUT
Market Cap	2.23B
Enterprise Value	2.01B
Income	-61.70M
Sales	0.00M
Book/sh	15.06
Cash/sh	17.39
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	29
IPO	Jan 02, 2015

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	10.29
P/C	8.92
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	21.18
Current Ratio	21.18
Debt/Eq	0.10
LT Debt/Eq	0.10
Option/Short	Yes / Yes

EPS (ttm)	-4.84
EPS next Y	-7.81
EPS next Q	-1.77
EPS this Y	-73.62%
EPS next Y	-21.24%
EPS next 5Y	-11.12%
EPS past 3/5Y	53.08% 41.62%
Sales past 3/5Y	- -
EPS Y/Y TTM	61.66%
Sales Y/Y TTM	-
EPS Q/Q	-77.78%
Sales Q/Q	-
Earnings	Aug 04 BMO
EPS/Sales Surpr.	-29.55% -

Insider Own	36.11%
Insider Trans	-0.45%
Inst Own	89.90%
Inst Trans	29.13%
ROA	-37.70%
ROE	-46.63%
ROIC	-25.78%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	5.67%
SMA50	14.41%
SMA200	37.67%
Trades

Shs Outstand	14.40M
Shs Float	9.21M
Short Float	22.46%
Short Ratio	8.20
Short Interest	2.07M
52W High	161.38 -3.91%
52W Low	40.92 278.96%
Volatility	3.87% 7.51%
ATR (14)	9.16
RSI (14)	57.18
Beta	-0.23
Rel Volume	0.66
Avg Volume	252.32K
Volume	166,680

Perf Week	0.10%
Perf Month	3.60%
Perf Quarter	23.28%
Perf Half Y	91.42%
Perf YTD	48.15%
Perf Year	258.88%
Perf 3Y	718.23%
Perf 5Y	-49.52%
Perf 10Y	11.40%
Recom	1.00
Target Price	229.82
Prev Close	154.30
Price	155.07
Change %	0.50%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)